As per industry analysis on oncology molecular diagnostics by Fact.MR, the global market was valued at around US$ 1.7 Bn in 2020 and is anticipated to reach a valuation of US$ 4 Bn by 2031. Demand for oncology molecular diagnostics is driven by increasing prevalence of infectious diseases and cancer, rising funding towards R&D, increase in PoC (point of care) testing devices, and various […]